Balance Sheet
Cash Flow Statement
AmortizationAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Amortization of Goodwill (2024)

Historic Amortization of Goodwill for Legend Biotech (LEGN) over the last 2 years, with Q1 2025 value amounting to -$970000.0.

  • Legend Biotech's Amortization of Goodwill changed N/A to -$970000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was -$974423.0, marking a year-over-year change of. This contributed to the annual value of -$4423.0 for FY2024, which is N/A changed from last year.
  • Legend Biotech's Amortization of Goodwill amounted to -$970000.0 in Q1 2025.
  • Legend Biotech's 5-year Amortization of Goodwill high stood at -$4423.0 for Q4 2024, and its period low was -$970000.0 during Q1 2025.